Stocktoria
Taysha Gene Therapies, Inc. TSHA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-24
Chart by TradingView
4/9
Piotroski F — financial health
-0.53
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $9.8M | $8.3M | $15.5M | $2.5M | — |
| Operating income | -$110.5M | -$91.5M | -$72.4M | -$162.4M | -$173.3M |
| Net income | -$109.0M | -$89.3M | -$111.6M | -$166.0M | -$174.5M |
| Operating cash flow | -$93.1M | -$81.2M | -$73.0M | -$88.4M | -$117.0M |
| Free cash flow | -$93.8M | -$81.6M | -$76.9M | -$109.0M | -$132.3M |
| Total assets | $343.3M | $160.4M | $172.7M | $126.3M | $214.0M |
| Total liabilities | $96.4M | $88.8M | $97.8M | $125.3M | $118.6M |
| Shareholders' equity | $246.9M | $71.5M | $74.9M | $949,000 | $95.4M |
| Ratios | |||||
| Operating margin | -1130.6% | -1097.6% | -468.8% | -6492.7% | — |
| Net margin | -1115.3% | -1071.6% | -722.1% | -6635.3% | — |
| FCF margin | -960.1% | -979.2% | -497.6% | -4356.9% | — |
| Return on assets | -31.7% | -55.7% | -64.6% | -131.5% | -81.6% |
| Return on equity | -44.1% | -124.8% | -148.9% | -17493.6% | -183.0% |
| Debt / equity | 0.20× | 0.61× | 0.54× | 40.01× | 0.39× |
| Current ratio | 12.23 | 5.42 | 4.08 | 1.54 | 3.08 |
| Revenue growth | 17.3% | -46.1% | 517.5% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 461,856 | $2.1M |
| RENAISSANCE TECHNOLOGIES LLC | 413,203 | $1.8M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.53 (distress)
- Working capital / assets 0.868
- Retained earnings / assets -2.072
- EBIT / assets -0.322
- Equity / liabilities 2.562
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001806310 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.